200
Participants
Start Date
February 8, 2023
Primary Completion Date
July 3, 2025
Study Completion Date
July 3, 2025
Finerenone (Kerendia, BAY94-8862)
Film-coated tablet, oral administration, once daily (OD), dosage based on the eGFR and serum potassium thresholds
PSRI Institute of Renal Sciences, New Delhi
Vardhman Mahavir Medical College & Safdarjung Hospital (VMMC-SJH), New Delhi
Accord Superspeciality Hospital, Faridabad
M.V. Hospital & Research Centre 314/30, Chowk Lucknow
Muljibhai Patel Urological Hospital (MPUH) (Kidney Hospital), Nadiād
Global Hospital-Super Speciality And Transplant Centre, Mumbai
Dr Balabhai Nanavati Hospital, Mumbai, Maharashtra,
Lancelot Medical Centre, Mumbai
Nizam's Institute of Medical Sciences (NIMS), Hyderabad
Kempegowda Institute of Medical Sciences Hospital & R C, Bangalore
Bhate Hospital, Karnataka
Government Stanley Medical College and Hospital, Chennai
Jawaharlal Institute Of Postgraduate Medical Education and R, Gorimedu
Christian Medical College, Vellore
Medica Superspecialty Hospital, Kolkata
All India Institute of Medical Sciences, Bhubaneswar
Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow
Lead Sponsor
Bayer
INDUSTRY